Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the manufacture, research and development of active pharmaceutical ingredients (API). Its products include pain management for skeletal muscle pain & migraine, immunosuppressant for reducing immune activity after organ transplant, antifungal such as fluconazole, caspofungin & micafungin, oncology that act against cancers, lowering cholesterol & chronic heart disease and other APIs for lowering cholesterol and anti diabetic drugs. The company was founded on May 19, 1964 and is headquartered in New Taipei, Taiwan.